This brand name is authorized in Poland.
The drug DEXADENT contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
E2287TKU04 - DEXAMETHASONE ACETATE, UNSPECIFIED FORM
|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
|
2
|
UNII
Y3720KZ4TQ - FRAMYCETIN SULFATE
|
3
|
UNII
19371312D4 - POLYMYXIN B SULFATE
|
|
Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A01AD | Other agents for local oral treatment | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| PL | Rejestru Produktów Leczniczych | 100114433 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.